G

GUJARAT KIDNEY AND SUPER SPECI

GKSL
Market snapshot · 2026-08-13 23:50 UTC

136.18

+₹3.02 (+2.27%)

MARKET CAP

₹1.07K Cr

STOCK P/E

54.7x

52W HIGH

₹148.34

52W LOW

₹98.36

BOOK VALUE

₹40.57

EPS

₹2.49

ROE

11.93%

SECTOR

Health Care

DEBT/EQUITY

11.43

VOLUME

3.96L

P/B RATIO

3.36x

PEG RATIO

Sector

Health Care

Themes

Hospitals & Diagnostic Centres
₹143.27₹132.29₹121.32₹110.34₹99.36VolumeDec '25Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26

AI Summary

✦ Clartha

Forecast

Analyst targets, estimate history, and probabilistic forward ranges for GKSL.

Coverage check

Price Forecast

Current
₹136.18
High Target
Median Target
Low Target
Now₹136.18Dec '25Now12M Target
Price history (1Y)
Analyst target range

Probabilistic Range

Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.

Time horizonRange ()Probability
3M₹124.52 - ₹180.7880%
6M₹126.99 - ₹215.1680%
12M₹138.20 - ₹291.3080%
Realized vol: +29.1% · Drift: +43.0%

Revenue Forecast

₹ Cr
Mar '26Current₹9.0
Sep 2026 ETrend estimate range
High₹12.1Base₹11.2Low₹10.3
Jun '25: ₹11.0 · Sep '25: ₹10.0 · Dec '25: ₹10.0 · Mar '26: ₹9.0 · Sep '26: ₹11.2 · Dec '26: ₹11.2
Jun '25Sep '25Dec '25Mar '26Sep '26 EDec '26 E11.010.010.09.011.211.2
PastCurrentTrend estimate: Low / Base / High

EPS Forecast

₹ / share
Mar '26Current₹0.17
Sep 2026 ETrend estimate range
High₹0.31Base₹0.28Low₹0.25
Jun '25: ₹0.69 · Sep '25: ₹0.40 · Dec '25: ₹0.30 · Mar '26: ₹0.17 · Sep '26: ₹0.28 · Dec '26: ₹0.21
Jun '25Sep '25Dec '25Mar '26Sep '26 EDec '26 E0.690.400.300.170.280.21
PastCurrentTrend estimate: Low / Base / High
Analyst price target unavailable from FMP/yfinance. Analyst pillar unavailable from FMP/yfinance.
Market Intelligence

Multi-factor synthesis of 5 key dimensions

Overall Outlook
Mixed
39%
Analyst Consensus
Unavailable

Analyst coverage unavailable

Mean upsideNot available

Fundamentals

Moderate

Fundamentals institutional score is 50 using EVA spread proxy -0.1%; growth durability 50.6.

Valuation

Premium valuation

Valuation institutional score is 8 using relative multiple z-scores where peer dispersion is available.

Analyst Consensus

Unavailable

No usable analyst target or recommendation data was available.

Technical Structure

Mixed Momentum

Technicals institutional score is 57 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.

Market Sentiment

Unavailable

This data source has not been supplied for the decision payload.

Signal Summary

Market intelligence remains Mixed. Available evidence provides partial support, while fundamentals and valuation remain considerations.

Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.

Fundamentals ModerateValuation Premium valuationTechnical Structure Mixed Momentum

Key Data Points

Mean Target PriceUnavailable
Mean UpsideNot available
Technical Score57%
Fundamental Score50%
Data CoverageMedium

Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.

Valuation Metrics

Trading 19.8% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.25). Confidence: 89%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Overvalued

5Y Average

48.99

Current

54.69

Overvalued

52.24

Undervalued

43.20

EV/EBITDA
Strongly Overvalued

5Y Average

26.73

Current

29.84

Overvalued

28.73

Undervalued

24.45

P/S
Strongly Overvalued

5Y Average

11.73

Current

13.09

Overvalued

12.60

Undervalued

10.73

Peers & Comparison

Sector: Health Care · Theme: Hospitals & Diagnostic Centres

Hospitals & Diagnostic Centres Peers8 peers
Avg P/E: 76.4x
CompanyRev. GrowthMarginP/Evs Avg52W Perf.
GPT HEALTHCARE LIMITED
GPTHEALTHHospitals & Diagnostic Centres
+17.8%9.6%
26.9x
Undervalued
-65% vs avg
-2.2%
JUPITER LIFE LINE HOSP L
JLHLHospitals & Diagnostic Centres
+18.2%12.0%
55.1x
Undervalued
-28% vs avg
+7.5%
FORTIS HEALTHCARE LTD
FORTISHospitals & Diagnostic Centres
+17.5%11.0%
65.4x
Fair
-14% vs avg
-3.4%
NARAYANA HRUDAYALAYA LTD.
NHHospitals & Diagnostic Centres
+80.4%9.0%
45.2x
Undervalued
-41% vs avg
+1.1%
GLOBAL HEALTH LIMITED
MEDANTAHospitals & Diagnostic Centres
+26.5%11.9%
68.4x
Fair
-10% vs avg
+1.4%
ASTER DM QUALITY CARE LTD
ASTERDMHospitals & Diagnostic Centres
+21.6%6.5%
134.5x
Premium
+76% vs avg
+36.7%
KRISHNA INST OF MED SCI L
KIMSHospitals & Diagnostic Centres
+35.3%4.8%
156.8x
Premium
+105% vs avg
+7.9%
APOLLO HOSPITALS ENTER. L
APOLLOHOSPHospitals & Diagnostic Centres
+18.1%7.7%
59.2x
Undervalued
-23% vs avg
+9.9%
WHY THESE PEERS

Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹9.24 CrMar 2026

Latest net profit

₹1.37 CrMar 2026

Latest EPS

₹0.17Mar 2026

Net margin

17.1%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%15.0%30.0%45.0%60.0%0.00 Cr3.00 Cr6.00 Cr9.00 Cr12 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr3.00 Cr6.00 Cr9.00 Cr12 Cr₹0₹0₹0₹1₹1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherOtheradjustmentsNet Profit0.00 Cr3.00 Cr6.00 Cr9.00 Cr12 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2023Mar 2024Mar 2025Mar 2026-90 Cr0.00 Cr90 Cr180 Cr270 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +9.418.518.0211.459.649.769.24
Expenses +4.554.705.715.125.555.627.66
Operating Profit4.863.812.316.334.094.141.58
OPM %51.65%44.77%28.80%55.28%42.43%42.42%17.10%
Other Income +0.040.020.040.000.020.030.45
Interest0.160.110.120.130.230.290.50
Depreciation0.740.660.750.800.750.720.67
Profit before tax4.003.061.485.403.133.160.86
Tax %26.25%27.78%14.19%27.78%26.20%26.27%-59.30%
Net Profit +2.962.211.263.902.302.331.37
EPS in Rs18.3913.730.220.690.400.300.17
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderDec 2025Mar 2026Jun 2026
Promoters71.45%71.45%71.45%
FII10.47%4.89%4.89%
DII1.67%0.56%0.56%
Public16.40%23.10%23.10%
Others0.01%
Jun 2026
Promoters
FII
DII
Public

Events Timeline

Board Meeting Intimation for Approval Of Quarterly Results And Other Businesses

Aug 06, 2026PDFCompany Reports Open

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Jul 23, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Change in Management

Jul 21, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 10, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Change in Management

Jul 09, 2026PDFCompany Reports Open